Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical use of p53 in Barrett's esophagus.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jul 2006

Keswani Rajesh N, Noffsinger Amy, Waxman Irving, Bissonnette Marc

Abstract excerpt

Barrett's esophagus is an established precursor to esophageal adenocarcinoma. Whereas most patients with Barrett's esophagus do not progress to adenocarcinoma, patients with progression have a poor prognosis. Current management strategies use frequent endoscopic surveillance and multiple nontargeted biopsies. This approach, however, may miss dysplastic areas. Furthermore, given the relatively high prevalence of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Barrett Esophagus
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Loss of Heterozygosity

Share to Mutation

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 16835318
DOI: 10.1158/1055-9965.EPI-06-0010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical use of p53 in Barrett's esophagus.PMID 16835318Read ↗

Barrett's esophagus. The significance of p53 in clinical practice.Semantic proximity Read ↗

Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry.Semantic proximity Read ↗

TP53 gene mutations are rare in nondysplastic Barrett's esophagus.Semantic proximity Read ↗

Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer.Semantic proximity Read ↗

Abnormal<i>TP53</i>predicts risk of progression in patients with Barrett’s esophagus regardless of a diagnosis of dysplasiaSemantic proximity Read ↗

Molecular biologic assessment of Barrett's esophagus.Semantic proximity Read ↗

p53 in esophageal adenocarcinoma: a critical reassessment of mutation frequency and identification of 72Arg as the dominant allele.Semantic proximity Read ↗

Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases.Semantic proximity Read ↗

p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.Semantic proximity Read ↗

Molecular Biology of Barrett’s AdenocarcinomaSemantic proximity Read ↗

p53 gene mutations in Barrett's epithelium and esophageal cancer.Semantic proximity Read ↗

Overexpression of p53 protein in Barrett's syndrome with malignant transformation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.